JP2018150298A5 - - Google Patents

Download PDF

Info

Publication number
JP2018150298A5
JP2018150298A5 JP2018044050A JP2018044050A JP2018150298A5 JP 2018150298 A5 JP2018150298 A5 JP 2018150298A5 JP 2018044050 A JP2018044050 A JP 2018044050A JP 2018044050 A JP2018044050 A JP 2018044050A JP 2018150298 A5 JP2018150298 A5 JP 2018150298A5
Authority
JP
Japan
Prior art keywords
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018044050A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018150298A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2018150298A publication Critical patent/JP2018150298A/ja
Publication of JP2018150298A5 publication Critical patent/JP2018150298A5/ja
Pending legal-status Critical Current

Links

JP2018044050A 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法 Pending JP2018150298A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361779619P 2013-03-13 2013-03-13
US61/779,619 2013-03-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2015562108A Division JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法

Related Child Applications (3)

Application Number Title Priority Date Filing Date
JP2018153231A Division JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Division JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Division JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Publications (2)

Publication Number Publication Date
JP2018150298A JP2018150298A (ja) 2018-09-27
JP2018150298A5 true JP2018150298A5 (https=) 2019-01-31

Family

ID=50241450

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法
JP2018044050A Pending JP2018150298A (ja) 2013-03-13 2018-03-12 ベンゾオキサゼピン化合物の作製方法
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Pending JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2015562108A Active JP6363120B2 (ja) 2013-03-13 2014-03-12 ベンゾオキサゼピン化合物の作製方法
JP2017135083A Active JP6442005B2 (ja) 2013-03-13 2017-07-10 ベンゾオキサゼピン化合物の作製方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2018153231A Active JP6663459B2 (ja) 2013-03-13 2018-08-16 ベンゾオキサゼピン化合物の作製方法
JP2018219226A Pending JP2019089762A (ja) 2013-03-13 2018-11-22 ベンゾオキサゼピン化合物の作製方法
JP2020032846A Pending JP2020114814A (ja) 2013-03-13 2020-02-28 ベンゾオキサゼピン化合物の作製方法

Country Status (15)

Country Link
US (1) US9303043B2 (https=)
EP (3) EP3404032B1 (https=)
JP (6) JP6363120B2 (https=)
KR (3) KR101871133B1 (https=)
CN (2) CN108929333A (https=)
AR (1) AR095365A1 (https=)
AU (3) AU2014230812B2 (https=)
BR (1) BR112015020716A2 (https=)
CA (6) CA2897618A1 (https=)
IL (1) IL240793A0 (https=)
MX (1) MX2015011438A (https=)
NZ (1) NZ711192A (https=)
RU (2) RU2018109979A (https=)
SG (2) SG11201507394RA (https=)
WO (1) WO2014140073A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109293674A (zh) 2013-12-16 2019-02-01 豪夫迈·罗氏有限公司 Gdc-0032的多晶型物、其制备方法和药物用途
WO2017001658A1 (en) 2015-07-02 2017-01-05 F. Hoffmann-La Roche Ag Benzoxazepin oxazolidinone compounds and methods of use
EP4212536B1 (en) 2015-07-02 2025-02-19 F. Hoffmann-La Roche AG Benzoxazepin oxazolidinone compounds and methods of use
CN105906635A (zh) * 2016-06-08 2016-08-31 上海大学 全氟烷基苯并氮杂*并喹喔啉衍生物及其合成方法
CN114716377A (zh) 2016-07-29 2022-07-08 日本烟草产业株式会社 吡唑-酰胺化合物的制造方法
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TWI770093B (zh) 2016-12-15 2022-07-11 瑞士商赫孚孟拉羅股份公司 製備苯并氧氮呯(benzoxazepin)噁唑啶酮化合物之方法
CN108752237A (zh) * 2018-07-05 2018-11-06 四川青木制药有限公司 一种对氨基苯甲脒盐酸盐的新制备方法
JPWO2020130125A1 (ja) 2018-12-21 2021-11-04 第一三共株式会社 抗体−薬物コンジュゲートとキナーゼ阻害剤の組み合わせ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
WO2000024720A1 (en) * 1998-10-23 2000-05-04 Dow Agrosciences Llc 3-(substituted phenyl)-5-(substituted cyclopropyl)-1,2,4-triazole compounds
WO2003006151A1 (en) 2001-07-12 2003-01-23 Avecia Limited Microencapsulated catalyst, methods of preparation and methods of use thereof
CA2463441A1 (en) * 2001-10-12 2003-05-08 Bayer Pharmaceuticals Corporation Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
CA2627839C (en) 2005-11-02 2014-08-19 Bayer Healthcare Ag Pyrrolo[2,1-f] [1,2,4] triazin-4-ylamines igf-1r kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
AU2007309149C1 (en) * 2006-10-23 2013-04-04 Sgx Pharmaceuticals, Inc. Bicyclic triazoles as protein kinase modulators
CA2667453A1 (en) * 2006-10-23 2008-05-02 Sgx Pharmaceuticals, Inc. Triazolo-pyridazine protein kinase modulators
WO2008088881A1 (en) 2007-01-19 2008-07-24 Xcovery, Inc. Kinase inhibitor compounds
US8354528B2 (en) * 2007-10-25 2013-01-15 Genentech, Inc. Process for making thienopyrimidine compounds
WO2009105500A1 (en) * 2008-02-21 2009-08-27 Schering Corporation Compounds that are erk inhibitors
ES2480994T3 (es) 2008-03-31 2014-07-29 Genentech, Inc. Compuestos de tipo benzopirano y benzoxepina inhibidores de PI3K y métodos de uso
GB0810902D0 (en) 2008-06-13 2008-07-23 Astex Therapeutics Ltd New compounds
ES2558742T3 (es) 2009-09-28 2016-02-08 F. Hoffmann-La Roche Ag Compuestos inhibidores de PI3K de benzoxepina y métodos de uso
ES2570569T3 (es) * 2009-09-28 2016-05-19 Hoffmann La Roche Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso
US9409918B2 (en) * 2009-10-29 2016-08-09 Merck Sharp & Dohme Corp. Bridged bicyclic piperidine derivatives and methods of use thereof
CN102558167A (zh) * 2010-12-29 2012-07-11 中国医学科学院药物研究所 Gk和ppar双重激动活性的噻唑烷二酮衍生物
WO2012126901A1 (en) 2011-03-21 2012-09-27 F. Hoffmann-La Roche Ag Benzoxazepin compounds selective for pi3k p110 delta and methods of use
NO3175985T3 (https=) * 2011-07-01 2018-04-28
WO2013182668A1 (en) 2012-06-08 2013-12-12 F. Hoffmann-La Roche Ag Mutant selectivity and combinations of a phosphoinositide 3 kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer

Similar Documents

Publication Publication Date Title
JP2019089762A5 (https=)
JP2018150298A5 (https=)
JP2018168171A5 (https=)
JP2017008120A5 (https=)
JP2020515557A5 (https=)
JP2019194236A5 (https=)
JP2018024670A5 (https=)
JP2020007340A5 (https=)
JP2012107057A5 (https=)
JP2020534795A5 (https=)
JP2018521020A5 (https=)
JP2017514877A5 (https=)
JP2017137500A5 (https=)
JP2019164961A5 (https=)
JP2019124943A5 (https=)
JP2021503553A5 (https=)
JP2013532130A5 (https=)
JP2018186811A5 (https=)
JP2020183924A5 (https=)
JP2018116258A5 (https=)
JP2021129286A5 (https=)
JP2018162319A5 (https=)
JP2021512134A5 (https=)
JP2019210167A5 (https=)
JP2011037885A5 (https=)